The Relationship between the Clinical Course of SARS-CoV-2 Infections and Expression of Bruton's Tyrosine Kinase.
Rezaei M, Babamahmoodi A, Mirahmadi A, Bineshfar N, Mahmoudi S, Ghadimi S, Valizadeh M, Malakouti T, Taheri FT, Mohammadpour H, Azadani FN, Ziai SA, Poorhosseini SM, Marjani M.
Rezaei M, et al. Among authors: taheri ft.
Infect Disord Drug Targets. 2025;25(1):e270624231361. doi: 10.2174/0118715265301312240529044923.
Infect Disord Drug Targets. 2025.
PMID: 38939988